Home/Filings/4/0001181431-05-051327
4//SEC Filing

RENOVIS INC 4

Accession 0001181431-05-051327

CIK 0001118361operating

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 4:13 PM ET

Size

16.4 KB

Accession

0001181431-05-051327

Insider Transaction Report

Form 4
Period: 2005-09-08
Schmidt William K
V.P., Clinical Research
Transactions
  • Sale

    Common Stock

    2005-09-08$14.00/sh100$1,4001,172 total
  • Sale

    Common Stock

    2005-09-09$14.00/sh400$5,6001,172 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2005-09-09400119,500 total
    Exercise: $8.05From: 2005-07-22Exp: 2014-07-21Common Stock (400 underlying)
  • Exercise/Conversion

    Common Stock

    2005-09-08$8.05/sh+100$8051,272 total
  • Exercise/Conversion

    Common Stock

    2005-09-09$8.05/sh+400$3,2201,572 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2005-09-08100119,900 total
    Exercise: $8.05From: 2005-07-22Exp: 2014-07-21Common Stock (100 underlying)
Footnotes (2)
  • [F1]Disposition of securities made pursuant to a 10b5-1 plan adopted by Dr. Schmidt on March 9, 2005.
  • [F2]Stock option was granted under the Renovis, Inc. Stand-Alone Option Grant to William K. Schmidt on July 22, 2004.

Issuer

RENOVIS INC

CIK 0001118361

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001118361

Filing Metadata

Form type
4
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:13 PM ET
Size
16.4 KB